RxDoctor Payments Data

Jimmy Chenowith

Psychiatric/Mental Health · Avon, INNPI 1881353415

Payments from drug & device makers

$3,376in general payments, 2019–2025

Across 214 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$457
  • AbbVie$446
  • Otsuka America Pharmaceutical, Inc.$389
  • Johnson & Johnson$348
  • Takeda Pharmaceuticals U.S.A., Inc.$273
  • Neos Therapeutics, LP$234
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$3,376100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,376 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$10,797
Medicare patients
23
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide13$7,112
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$710
Hydroxyzine Hcl16$497
Quetiapine Fumarate27$427
Bupropion XlBupropion Hcl26$410
Sertraline Hcl19$235
Trazodone Hcl35$213
Clonazepam13$150
Escitalopram Oxalate11$148
Lamotrigine11$135
Alprazolam26$123
Zolpidem Tartrate11$118
Clonidine Hcl21$95
Gabapentin12$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$273$7,11213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Avon

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →